Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anthrax lethal factor is a MAPK kinase protease

Anthrax lethal factor is a MAPK kinase protease

US Patent 6893835 · Granted May 17, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified anthrax toxin protective antigen2020
Antibodies to tumor endothelial marker 82019
Protease-deficient bacillus anthracis2019
Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin2019
Monoclonal antibodies that neutralize anthrax toxins2018
Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis 2018
Engineered anthrax lethal toxin for targeted delivery2017
Monoclonal antibodies that neutralize anthrax toxins2017
Protease-deficient Bacillus anthracis2017
Mutated anthrax toxin protective antigen proteins that specifically target cells2016
Antibodies to tumor endothelial marker 82016
Monoclonal antibodies that neutralize anthrax toxins2015